Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.

Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ibuki R, Higaki K, Kimura T.

J Control Release. 2006 May 1;112(1):51-6. Epub 2006 Mar 20.

PMID:
16545477
2.

Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.

Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ohike A, Ibuki R, Higaki K, Kimura T.

J Control Release. 2005 Nov 28;108(2-3):386-95. Epub 2005 Oct 25.

PMID:
16253377
3.
4.

Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).

Okimoto K, Tokunaga Y, Ibuki R, Irie T, Uekama K, Rajewski RA, Stella VJ.

Int J Pharm. 2004 Nov 22;286(1-2):81-8.

PMID:
15501004
5.

Effect of experimental acute renal and hepatic failure on absorption of tacrolimus in rat small intestine.

Tamura S, Ohike A, Tokunaga Y, Ibuki R, Amidon GL, Sezaki H, Yamashita S.

Drug Metab Pharmacokinet. 2004 Jun;19(3):190-7.

6.

Formulation development of inhalation powders for FK888 with carrier lactose using Spinhaler and its absorption in healthy volunteers.

Nakate T, Yoshida H, Ohike A, Tokunaga Y, Ibuki R, Kawashima Y.

J Control Release. 2004 May 31;97(1):19-29.

PMID:
15147801
7.

In vitro release of Tacrolimus from Tacrolimus ointment and its speculated mechanism.

Yoshida H, Tamura S, Toyoda T, Kado K, Ohnishi N, Ibuki R.

Int J Pharm. 2004 Feb 11;270(1-2):55-64.

PMID:
14726122
8.

Establishment of new preparation method for solid dispersion formulation of tacrolimus.

Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, Higaki K, Kimura T.

Int J Pharm. 2003 Nov 28;267(1-2):79-91.

PMID:
14602386
9.

Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers.

Nakate T, Yoshida H, Ohike A, Tokunaga Y, Ibuki R, Kawashima Y.

Eur J Pharm Biopharm. 2003 Nov;56(3):319-25.

PMID:
14602173
10.

The site-specific transport and metabolism of tacrolimus in rat small intestine.

Tamura S, Tokunaga Y, Ibuki R, Amidon GL, Sezaki H, Yamashita S.

J Pharmacol Exp Ther. 2003 Jul;306(1):310-6. Epub 2003 Apr 3.

PMID:
12676880
11.

Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.

Nakate T, Yoshida H, Ohike A, Tokunaga Y, Ibuki R, Kawashima Y.

Eur J Pharm Biopharm. 2003 Mar;55(2):147-54.

PMID:
12637090
12.
13.

[Labial adhesion in a reproductive woman with difficulties of sexual intercourse and urination: a case report].

Uei T, Katou Y, Shimizu N, Yamanaka H, Seki M, Ibuki R.

Hinyokika Kiyo. 2000 Jun;46(6):433-6. Review. Japanese.

14.

Effect of truncal vagotomy on gallbladder bile kinetics in conscious dogs.

Muramatsu S, Sonobe K, Tohara K, Tanaka T, Mizumoto A, Ibuki R, Suzuki H, Itoh Z.

Neurogastroenterol Motil. 1999 Oct;11(5):357-64.

PMID:
10520167
15.

Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.

Okimoto K, Ohike A, Ibuki R, Aoki O, Ohnishi N, Rajewski RA, Stella VJ, Irie T, Uekama K.

J Control Release. 1999 Aug 5;60(2-3):311-9.

PMID:
10425336
16.

Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.

Okimoto K, Ohike A, Ibuki R, Aoki O, Ohnishi N, Irie T, Uekama K, Rajewski RA, Stella VJ.

Pharm Res. 1999 Apr;16(4):549-54.

PMID:
10227711
17.

Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane.

Weiss G, Yamaguchi H, Ibuki R, Yasumura M, Ohnishi N.

J Microencapsul. 1998 May-Jun;15(3):335-46.

PMID:
9608396
18.

Long-term observations of uterine contractions in nonpregnant dogs.

Ibuki R, Haga N, Muramatsu S, Mizumoto A, Itoh Z.

Biol Reprod. 1997 Mar;56(3):632-9.

PMID:
9047007
19.

[Strain gauge force transducer measurement of uterine contraction in conscious non-pregnant dogs].

Ibuki R, Mizumoto A, Ito S.

J Smooth Muscle Res. 1995 Dec;31(6):525-8. Japanese. No abstract available.

PMID:
8867994
20.

Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior.

Ueda S, Ibuki R, Kawamura A, Murata S, Takahashi T, Kimura S, Hata T.

J Drug Target. 1994;2(2):133-40.

PMID:
8069590
21.

Nuclear factor I stimulates transcription of the adenovirus 12 E1A gene in a cell-free system.

Koikeda S, Ibuki R, Sawada Y, Nagata K, Shibata H, Masamune Y, Nakanishi Y.

Biochim Biophys Acta. 1990 Jan 30;1048(1):85-92.

PMID:
1688713
22.

[Pregnancy, delivery, and postnatal care of schizophrenic patients].

Yoshida M, Mukawa S, Fukuda M, Ibuki R, Igarashi M.

Josanpu Zasshi. 1988 Mar;42(3):234-40. Japanese. No abstract available.

PMID:
3373796
23.

[Proceedings: Radioimmunoassay of HCG using anti HCG beta-subunit].

Ibuki R, Igarashi M.

Nihon Naibunpi Gakkai Zasshi. 1974 Feb 20;50(2):182. Japanese. No abstract available.

PMID:
4476324
24.

[Study of feedback mechanism of steroid hormones on the hypothalamic center].

Ibuki R.

Nihon Sanka Fujinka Gakkai Zasshi. 1968 Nov;20(11):1505-14. Japanese. No abstract available.

PMID:
5752840

Supplemental Content

Support Center